Login / Signup

YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer.

Ling-Chen LiXie-Wan ChenLing FangChun-Li JianYong-Xin YuXing-Yun LiaoJian-Guo Sun
Published in: Canadian respiratory journal (2023)
. This trial is registered with NCT03513666.
Keyphrases
  • small cell lung cancer
  • epidermal growth factor receptor
  • phase iii
  • study protocol
  • tyrosine kinase
  • phase ii
  • clinical trial
  • wild type
  • open label
  • randomized controlled trial